» Articles » PMID: 36106326

Psoriasis and Medical Ramifications: A Comprehensive Analysis Based on Observational Meta-analyses

Overview
Specialty General Medicine
Date 2022 Sep 15
PMID 36106326
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Based on a large number of systematic reviews and meta-analyses exploring the relationship between psoriasis and various health outcomes, we conducted an comprehensive analysis to assess the strength and evidence for the association between psoriasis and medical end-point ramifications in patients.

Methods: We searched related meta-analyses, investigating the links between psoriasis and medical ramifications from three databases. All summary effect sizes, 95% CIs, heterogeneity, and small-study effects in the included meta-analyses were recalculated. We assessed the methodological quality of included articles with the AMSTAR 2 tool and graded the epidemiological evidence. Subgroup analysis based on the severity of psoriasis and study design were also performed.

Results: A total of 38 articles comprising 85 unique meta-analyses were included in this study. Although 69 outcomes were statistically significant, only 8 outcomes (nonvascular dementia, ulcerative colitis, pediatric dyslipidemia, gestational diabetes, gestational hypertension, fracture, multiple sclerosis, and schizophrenia) showed a high quality of epidemiological evidence.

Conclusion: We found that psoriasis increased the risk of 69 health outcomes, and 8 outcomes were graded as high-quality evidence. No evidence was found that psoriasis was beneficial for any medical end point. However, to verify our results, more large-sample, multi-center prospective cohort studies are needed.

Citing Articles

Direct impact of psoriasis on gingival crevicular fluid levels of VEGF-A in periodontitis patients: a mediation analysis.

Jimenez C, Fernandez J, Rodriguez C, Mancilla J, Pellegrini E, Hernandez M Front Immunol. 2024; 15:1477587.

PMID: 39512356 PMC: 11540697. DOI: 10.3389/fimmu.2024.1477587.

References
1.
Parisi R, Iskandar I, Kontopantelis E, Augustin M, Griffiths C, Ashcroft D . National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 2020; 369:m1590. PMC: 7254147. DOI: 10.1136/bmj.m1590. View

2.
Islam M, Poly T, Yang H, Wu C, Li Y . Increase Risk of Multiple Sclerosis in Patients with Psoriasis Disease: An Evidence of Observational Studies. Neuroepidemiology. 2019; 52(3-4):152-160. DOI: 10.1159/000495112. View

3.
Marrie R, Patten S, Tremlett H, Wolfson C, Leung S, Fisk J . Increased incidence and prevalence of psoriasis in multiple sclerosis. Mult Scler Relat Disord. 2017; 13:81-86. DOI: 10.1016/j.msard.2017.02.012. View

4.
Xie W, Huang H, Ji L, Zhang Z . Maternal and neonatal outcomes in pregnant women with psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Rheumatology (Oxford). 2021; 60(9):4018-4028. DOI: 10.1093/rheumatology/keab357. View

5.
Manolis A, Manolis T, Melita H, Manolis A . Psoriasis and cardiovascular disease: the elusive link. Int Rev Immunol. 2018; 38(1):33-54. DOI: 10.1080/08830185.2018.1539084. View